Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis

• Published in: Archives of biochemistry and biophysics Vol. 477; no. 1; pp. 12 - 19
• Main Authors: Boutin, Jean A., Saunier, Carine, Guenin, Sophie-Pénélope, Berger, Sylvie, Moulharat, Natacha, Gohier, Arnaud, Delagrange, Philippe, Cogé, Francis, Ferry, Gilles
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2008
• Subjects: Amino Acid Sequence; Animals; Base Sequence; Binding; Binding Sites; Blotting, Western; Catalysis; Catalytic activity; CHO Cells; Cricetinae; Cricetulus; Human quinone oxidoreductase 2 (hQR2); Humans; Melatonin; Melatonin - metabolism; Molecular Sequence Data; MT3; Mutagenesis; Quinone Reductases - chemistry; Quinone Reductases - genetics; Quinone Reductases - metabolism; Sequence Homology, Amino Acid; Site-directed mutagenesis; Human quinone oxidoreductase 2 (hQR2); Binding; Melatonin; Catalytic activity; MT3; Site-directed mutagenesis
• ISSN: 0003-9861; 1096-0384
• DOI: 10.1016/j.abb.2008.04.040

Melatonin is a neurohormone implicated in both biorhythm synchronization and neuroprotection from oxidative stress. Its functions are mediated by two G-protein-coupled-receptors (MT1 and MT2) and MT3, which corresponds to quinone oxidoreductase 2 (QR2). To determine the binding site of QR2 for melatonin, point mutations of residues crucial for the enzymatic activity of hQR2 were performed. The substitution of the hydrophobic residues Phe126, Ile128 and Phe178 by tyrosines at the active site significantly increased enzymatic activity and decreased the affinity of a structural analog of melatonin, the 2[ 125I]iodo-MCANAT. The mutation of residues implicated in zinc chelating (His 173; His 177) had no effect on radioligand binding. Destabilisation of the cofactor FAD by mutation N18E showed that 2[ 125I]iodo-MCANAT binding was closely linked to the conformational integrity of human QR2. Surprisingly, the mutations C222F and N161A, which are distant from the determined binding site of the ligand, increased the affinity of 2[ 125I]iodo-MCANAT for hQR2. What seems to better explain the binding variations among the mutants are the activity recorded with BNAH and coenzyme Q1. Various hypotheses are discussed based on the various parameters used in the study: nature of the substrates and co-substrates and nature of the amino acid changes. This study, which constitutes the first structural analysis of hQR2, should enable to better understand the biological role of melatonin on this enzyme and particularly, the discrepancies between the pharmacologies of the melatonin binding site (MT3) and the QR2 catalytic activity.